latest news

News / Pharma

Osmotica Will Commercialize and Supply Non-Surgical Droopy Lid Treatment via a Wholly Owned Subsidiary

Conni Bergmann Koury / August 5, 2020
News

Virtual ASRS Reporter’s Notebook

News

‘A Very Interesting Time’ and Other Insights from OIS Virtual Public Company Showcase

News

Retina Is Where the Research Is, and Other Big Players Want In

Deals / News / OIS Index

OIS Index Rallies Back from COVID-Driven Decline

Pharmaceuticals & Genetics

Osmotica Will Commercialize and Supply Non-Surgical Droopy Lid Treatment via a Wholly Owned Subsidiary

August 5, 2020
AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol

AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol

July 9, 2020
With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering

With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering

July 1, 2020
With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery

With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery

April 29, 2020
Adverum, Gene Therapy, and AMD

Adverum, Gene Therapy, and AMD

March 25, 2020
CRISPR and inherited retinal disease

CRISPR and inherited retinal disease

March 18, 2020

devices & diagnostics

Emerging Glaucoma Devices See Beyond IOP

Emerging Glaucoma Devices See Beyond IOP

May 27, 2020
Soft CL slows myopia in children

Soft CL slows myopia in children

January 22, 2020
Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

September 18, 2019
Why Link Between Cognition and Vision May Emerge as a Focus of Innovation

Why Link Between Cognition and Vision May Emerge as a Focus of Innovation

August 28, 2019
How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

August 20, 2019

SUBSCRIBE TO OUR NEWSLETTER

Get The Latest News In Ophthalmic Innovation To Your Inbox.
!
!
!
SUBSCRIBE

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

Subscribe To OIS News

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
!
!
!
Subscribe

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

stay connected

next ois event

about ois

The OIS programs are presented annually by Healthegy, Inc.

Learn more about our world-class conferences.

latest videos

Eyenuk’s EyeArt AI System Showing Its Value

Ocugen – Innovation Showcase at Ophthalmology Innovation Summit @ AAO 2019

Neuromodtronic – Innovation Showcase at Ophthalmology Innovation Summit @ AAO 2019

Noveome Biotherapeutics – Innovation Showcase at Ophthalmology Innovation Summit @ AAO 2019

Listen To The Podcast

OIS-Podcast-Episode-241

The Lindstrom Method: Say ‘Yes’ to Opportunities

August 4, 2020
OIS Podcast
OIS-Podcast-Episode-240

Dr. Ken Mandell’s Passion for Innovation

July 30, 2020
OIS Podcast
OIS-Podcast-Episode-239

Paul Hallen’s View of Retina from the Catbird’s Seat

July 21, 2020
OIS Podcast
OIS-Podcast-Episode-238

The Time is Nau!

July 15, 2020
OIS Podcast
OIS Israel Panel Dives Into Global Industry Insights and Innovation

OIS Israel Panel Dives Into Global Industry Insights and Innovation

July 9, 2020
OIS Podcast
OIS-Podcast-Episode-236

After West Point and Gulf War, ONL Therapeutics’ David Esposito Has Come Full Circle

June 30, 2020
OIS Podcast

Deals

OIS Index Q2

OIS Index Rallies Back from COVID-Driven Decline

July 9, 2020
With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

June 10, 2020
AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

May 20, 2020
Covid-19 Impact on Healthcare Company Valuations & Financings

Covid-19 Impact on Healthcare Company Valuations & Financings

April 22, 2020
OIS Index: No Immunity to Coronavirus Selloff

OIS Index: No Immunity to Coronavirus Selloff

April 8, 2020

watch videos from ois tv

OIS Index

OIS Index Rallies Back from COVID-Driven Decline

OIS Index Posts a Strong Finish to 2019

OIS Index Outperforms

OIS Index on Positive Upswing

OIS Index Deep in Bear Territory in Q3

OIS Index Posts Modest Gain for Q2; Ophthalmic Market Leader Alcon Joins Index

OIS Index Delivers Stellar First-Quarter 2019 Performance

ois press

@oistweets

most popular episodes

OIS 1 Year Podcast Anniversary

Year 1: What OIS Podcasts Were Most Popular? Part Two

OIS 1 Year Podcast Anniversary

Year 1: What OIS Podcasts Were Most Popular? Part One

OIS Podcast - Xiidra Prior to Shire: How SARcode Beat the Odds to Create a New Treatment for Dry Eye - Healthegy

Xiidra Prior to Shire: How SARcode Took on the Odds to Pursue a New Treatment for Dry Eye

OIS Podcast | Episode 198

With Positive Phase II Dry Eye Data in Hand, What’s Next for Aldeyra’s Promising Pipeline?